Bristol-Myers Squibb (NYSE: BMY) last traded at $59.12, down 0.77% on the session. The quote above updates while this page is open; the figures below are drawn from Bristol-Myers Squibb’s own filings and are restated only when a new one is published.
Bristol-Myers Squibb trades on NYSE under the ticker BMY. It is classified in the Healthcare sector, Pharmaceuticals industry. Its market capitalisation is $120.77 billion.
Healthcare sectorPharmaceuticalsListed on NYSE
Valuation measures for Bristol-Myers Squibb, derived from the latest quote and its most recent SEC filing.
| Market cap | $120.77B |
|---|---|
| Enterprise value | $177.36B |
| P/E ratio | 12.99 |
| Price / sales | 2.46 |
| Price / book | 5.41 |
|---|
| Beta | 0.20 |
|---|
Trailing-twelve-month figures tagged in Bristol-Myers Squibb's XBRL filings with the SEC.
| Revenue (TTM) | $49.19B |
|---|---|
| Net income (TTM) | $9.28B |
| EPS (TTM) | $4.55 |
| Gross margin | 70.16% |
| Return on equity | 41.59% |
| Cash | $8.72B |
Range and volume for BMY over the past 52 weeks.
| 52-week high | $68.64 |
|---|---|
| 52-week low | $42.52 |
| Volume | 9.25M |
| Average volume | 11.27M |
| Previous close | $59.58 |
Dividend history for Bristol-Myers Squibb over the trailing twelve months.
| Dividend yield | 4.25% |
|---|---|
| Dividend per share (TTM) | $2.51 |
| Payout ratio | 55.16% |
Other Healthcare companies tracked on FurlPay Markets.
Invest a chosen dollar amount in Bristol-Myers Squibb with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell BMY.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.